Use of mGluR5 antagonists for the treatment of GERD

Details for Australian Patent Application No. 2003241585 (hide)

Owner AstraZeneca AB

Inventors Lehmann, Anders; Stormann, Thomas M.; Mattsson, Jan

Agent Griffith Hack

Pub. Number AU-B-2003241585

PCT Number PCT/US03/16223

PCT Pub. Number WO2004/000316

Priority 0201943-8 20.06.02 SE

Filing date 19 June 2003

Wipo publication date 6 January 2004

Acceptance publication date 25 June 2009

International Classifications

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4439 (2006.01)

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 0201943-8 20.06.02 SE

4 March 2004 Application Open to Public Inspection

  Published as AU-B-2003241585

13 December 2007 Assignment before Grant

  AstraZeneca AB; NPS Pharmaceuticals, Inc. The application has been assigned to AstraZeneca AB

25 June 2009 Application Accepted

  Published as AU-B-2003241585

22 October 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003241586-APPARATUS AND METHOD FOR TRANSMIT TRANSPORT PROTOCOL TERMINATION

2003241584-Self-adjusting pliers